bendamustine hydrochloride has been researched along with Febrile Neutropenia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| DiMaria, E; Drennan, IR; Gerard, L; Kotchetkov, R; Nay, D; Prica, A; Susman, D | 1 |
| Abadi, U; Aumann, S; Aviv, A; Berger, T; Gafter-Gvili, A; Goldschmidt, N; Gurion, R; Harel, R; Horesh, N; Nachmias, B; Raanani, P; Shimony, S; Shmerts, E; Shochat, T | 1 |
| Cho, SH; Chung, JS; Jo, JC; Kim, DY; Shin, HJ | 1 |
| Abraham, I; Bartels, T; Kumar, A; McBride, A; Moore, L; Persky, DO | 1 |
| Jaksic, O; Lucijanic, M; Mitrovic, Z; Pejsa, V; Prka, Z; Vrkljan, A | 1 |
| Catalano, L; Cerchione, C; De Renzo, A; Della Pepa, R; Di Perna, M; Nappi, D; Pane, F; Picardi, M; Pugliese, N | 1 |
| Catalano, L; Cerchione, C; De Renzo, A; Della Pepa, R; Di Perna, M; Pane, F; Picardi, M; Pugliese, N | 1 |
1 trial(s) available for bendamustine hydrochloride and Febrile Neutropenia
| Article | Year |
|---|---|
Phase II study of safety and efficacy of BEB (bendamustine, etoposide, and busulfan) conditioning regimen for autologous stem cell transplantation in non-Hodgkin lymphoma.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Busulfan; Combined Modality Therapy; Etoposide; Febrile Neutropenia; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Premedication; Progression-Free Survival; Prospective Studies; Remission Induction; Transplantation Conditioning; Transplantation, Autologous; Young Adult | 2020 |
6 other study(ies) available for bendamustine hydrochloride and Febrile Neutropenia
| Article | Year |
|---|---|
Bendamustine and rituximab is well-tolerated and efficient in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma in elderly: A single center observational study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Febrile Neutropenia; Humans; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Middle Aged; Rituximab | 2023 |
Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma-a real-world multicenter retrospective cohort study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cohort Studies; Febrile Neutropenia; Humans; Immunotherapy; Lymphoma, Follicular; Retrospective Studies; Rituximab | 2023 |
Outcomes of primary and secondary prophylaxis of chemotherapy-induced and febrile neutropenia in bendamustine plus rituximab regimens in patients with lymphoma and chronic lymphocytic leukemia: real-world, single-center experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Febrile Neutropenia; Female; Humans; Incidence; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Rituximab; Treatment Outcome | 2021 |
Bendamustine-based conditioning prior to autologous stem cell transplantation is associated with high rate of febrile neutropenia and higher mortality.
Topics: Bendamustine Hydrochloride; Febrile Neutropenia; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Transplantation Conditioning; Transplantation, Autologous | 2019 |
Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignancies-bendamustine and G-CSF support.
Topics: Aged; Bendamustine Hydrochloride; Febrile Neutropenia; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Polyethylene Glycols | 2019 |
Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Febrile Neutropenia; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Quality of Life; Recombinant Proteins; Rituximab | 2017 |